Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Spectrum Pharmaceuticals Inc. logo

Spectrum Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 0 M  90-day average vol: 0

Previous close: 1.03  Open: 1.02  Bid:   Ask:
52 week range    
Last updated: Wednesday 19th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord



StockDividendMarket Cap (B)PEPrice ($)

SPPI Income Statement

Amortization of intangibles-21 M-24 M-38 M-26 M28 M0.0
Basic EPS from continuing operations-0.96-1.07-1.23-2.67-1.02-0.43
Basic EPS total-1.02-0.71-0.78-0.96-1.07-1.17-2.59-1.02-0.41
Basic weighted shares outstanding61 M65 M65 M73 M85 M103 M111 M124 M155 M183 M
Cost of sales29 M27 M28 M36 M47 M0.0
Depreciation-1 M-1 M-700000.0-500000.0-300000.0-200000.0-400000.0-300000.0
Depreciation unreconciled20 M24 M38 M28 M28 M
DepreciationAndAmortization20 M24 M38 M-500000.028 M-200000.0-400000.0-300000.0
Diluted EPS total-1.02-0.71-0.78-0.96-1.07-1.170.21-2.59-1.02-0.41
Diluted normalized net income/share-0.96-1.070.0-2.67-1.02-0.43
Diluted weighted shares outstanding61 M65 M65 M73 M85 M103 M111 M124 M155 M183 M
Fees-26 M
GainOnSaleOfSecurity-356000.02 M1 M
GeneralAndAdministrativeExpense-1 M-2 M-2 M88 M84 M63 M-2 M-2 M-2 M-2 M
Gross operating profit127 M160 M135 M85 M81 M83 M10 M
ImpairmentOfCapitalAssets-1 M-1 M-8 M-8 M-8 M0.0-20 M-3 M
Income before tax-37 M-44 M-50 M-72 M-108 M-129 M-145 M-171 M-158 M-78 M
Income restructuring and M&A68 M
Income taxes25 M2 M406000.0-2 M-17 M-2 M-9 M-60000.04000.02 M
Interest income3 M987000.0676000.0-998000.0
InterestExpenseNonOperating-217000.0-9 M-9 M9 M7 M340000.0-5 M-1 M
InterestExpenseOperating-1 M-3 M-3 M
LossAndLossAdjustmentExpectedIncurred26 M
MiscOtherSpecialCharges1 M-4 M-1 M238000.0-5 M10 M-9 M-3 M-11 M-5 M
Net income from total operations-62 M-46 M-51 M-70 M-91 M-127 M-135 M-171 M-158 M-78 M
NetIncomeCommonStockholders-62 M-46 M-51 M-70 M-91 M-127 M-135 M-171 M-158 M-78 M
NetIncomeContinuousOperations-62 M-46 M-51 M-70 M-91 M-127 M-135 M-171 M-158 M-78 M
NetIncomeDiscontinuousOperations6 M23 M10 M-192000.03 M
NetNonOperatingInterestIncomeExpense3 M987000.0676000.0-9 M-7 M-340000.05 M1 M-998000.0
NetOperatingInterestIncomeExpense-2 M-9 M-9 M163000.0968000.0
Operating income-39 M-32 M-41 M-63 M-97 M-138 M-141 M-170 M-148 M-71 M
Operating income before depreciation (EBITDA)-16 M-30 M-31 M-30 M-68 M-100 M-148 M-172 M-158 M-78 M
OperatingExpense166 M191 M176 M148 M178 M138 M141 M170 M148 M81 M
Other income net-1 M4 M1 M-238000.05 M-10 M9 M3 M11 M5 M
OtherGainLossFromDispositionOfDiscontinuedOperations6 M
OtherGandA-1 M-2 M-2 M88 M84 M63 M-2 M-2 M-2 M-2 M
OtherOperatingExpenses-648000.0-647000.0-1 M-411000.0-374000.0-1 M-2 M-2 M-2 M-1 M
RentAndLandingFees-1 M-2 M-2 M-1 M-2 M-2 M
Research & development expense47 M70 M51 M59 M66 M75 M79 M109 M87 M42 M
ResearchExpense47 M70 M51 M59 M66 M75 M79 M109 M87 M42 M
RestructringAndMnAIncome68 M
Revenue per share20 M24 M38 M-32 M28 M-220000.0
SalariesAndWages-13 M-12 M-12 M-3 M-18 M-18 M-20 M-8 M
Selling Gen & administrative expense99 M97 M87 M88 M84 M63 M61 M60 M60 M39 M
SellingAndMarketingExpense99 M97 M87 M61 M60 M60 M39 M
SellingExpense99 M97 M87 M61 M60 M60 M39 M
Special income/charges1 M1 M8 M8 M8 M8 M20 M3 M
Total Income available for interest expense (EBIT)-38 M-55 M-63 M-63 M-101 M-128 M-150 M-173 M-158 M-78 M
Total common shares outstanding65 M67 M68 M80 M103 M111 M114 M154 M177 M205 M
Total net income-62 M-46 M-51 M-70 M-91 M-127 M-135 M-171 M-158 M-78 M
Total ordinary shares205 M205 M205 M205 M205 M205 M205 M205 M205 M205 M
Total revenues156 M187 M163 M146 M128 M109 M10 M
TotalExpenses195 M191 M176 M183 M225 M0.0141 M170 M148 M81 M
TotalRevenue143 M187 M137 M120 M128 M109 M10 M
WriteDown28 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University